Skip to contentWIERENGA WENDALL — ONYX PHARMACEUTICALS INC insider: 309 transactions · InsiderLensWIERENGA WENDALL
- EVP, Research & Development at NEUROCRINE BIOSCIENCES INC · on record since Jan 23, 2006
- Director at XENOPORT INC · on record since May 4, 2006
- Director at ONYX PHARMACEUTICALS INC · on record since Dec 14, 2006
- Director at TRANZYME INC · on record since Dec 23, 2013
- Director at CYTOKINETICS INC · on record since Feb 10, 2011
- EVP, R&D at SANTARUS INC · on record since Jun 20, 2011
- Director at CONCERT PHARMACEUTICALS, INC. · on record since Mar 17, 2014
- Director at NEXMED INC · on record since Mar 11, 2014
- Director at Anacor Pharmaceuticals Inc · on record since Sep 12, 2014
- Director at Crinetics Pharmaceuticals, Inc. · on record since Jul 17, 2018
Insider trading activity of WIERENGA WENDALL
- Transactions on record
- 309
- since Sep 3, 2003
- Open-market buys
- 4
- $117K
- Open-market sells
- 84
- $5M
- Companies traded
- 10
- last filing Jul 16, 2025
Figures computed from official regulatory filings — methodology.
Companies where WIERENGA WENDALL has traded
- CYTOKINETICS INC81 tx · $4.6M · Jul 16, 2025
- Crinetics Pharmaceuticals, Inc.12 tx · $18.5K · Jun 13, 2025
- CONCERT PHARMACEUTICALS, INC.5 tx · Jun 18, 2018
- NEXMED INC9 tx · $39.2K · Jan 8, 2018
- TRANZYME INC12 tx · $45.2K · Dec 11, 2017
- XENOPORT INC61 tx · $1.7M · Jul 6, 2016
- Anacor Pharmaceuticals Inc6 tx · $78.8K · Jun 24, 2016
- SANTARUS INC8 tx · $9.1M · Jan 6, 2014
- ONYX PHARMACEUTICALS INC108 tx · $3.1M · Oct 3, 2013
Track record of WIERENGA WENDALL
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of WIERENGA WENDALL
Co-insiders of WIERENGA WENDALL
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
7 tx · $1.2M · Jan 23, 2006
BERNS PAUL LAnacor Pharmaceuticals Inc +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jul 16, 2025 | Award | 164 | 38.01 USD | $6.2K | SEC |
| Jun 13, 2025 | AwardD | 10,350 | 0.00 USD | $0 | SEC |
| Jun 13, 2025 | Award | 6,900 | 0.00 USD | $0 | SEC |
| May 14, 2025 | AwardD | 10,880 | 0.00 USD | $0 | SEC |
| May 14, 2025 | Award | 7,333 | 0.00 USD | $0 | SEC |
| Apr 21, 2025 | ExerciseD | -20,000 | 0.00 USD | $0 | SEC |
| Apr 21, 2025 | Sell | -20,000 | 38.46 USD | $769.2K | SEC |
| Apr 21, 2025 | Exercise | 20,000 | 6.21 USD | $124.2K | SEC |
| Apr 16, 2025 | Award | 162 | 38.56 USD | $6.2K | SEC |
| Jan 6, 2025 | Award | 127 | 48.93 USD | $6.2K | SEC |
| Dec 16, 2024 | ExerciseD | -742 | 0.00 USD | $0 | SEC |
| Dec 16, 2024 | Exercise | 742 | 7.37 USD | $5.5K | SEC |
| Dec 16, 2024 | Sell | -742 | 48.61 USD | $36.1K | SEC |
| Nov 26, 2024 | Sell | -742 | 50.00 USD | $37.1K | SEC |
| Nov 26, 2024 | Exercise | 742 | 7.37 USD | $5.5K | SEC |
| Nov 26, 2024 | ExerciseD | -742 | 0.00 USD | $0 | SEC |
| Oct 31, 2024 | Exercise | 4,452 | 7.37 USD | $32.8K | SEC |
| Oct 31, 2024 | Sell | -4,452 | 52.25 USD | $232.6K | SEC |
| Oct 31, 2024 | ExerciseD | -4,452 | 0.00 USD | $0 | SEC |
| Oct 3, 2024 | Award | 118 | 52.60 USD | $6.2K | SEC |
| Jul 3, 2024 | Award | 114 | 0.00 USD | $0 | SEC |
| Jun 11, 2024 | Award | 3,400 | 0.00 USD | $0 | SEC |
| Jun 11, 2024 | AwardD | 12,500 | 0.00 USD | $0 | SEC |
| May 16, 2024 | AwardD | 3,636 | 0.00 USD | $0 | SEC |
| May 16, 2024 | Award | 5,600 | 0.00 USD | $0 | SEC |